• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

The Future of ZimVie’s Spine Business Post-Sale: Exploring Potential Alternatives!

January 13, 2024 By SPINEMarketGroup

In a strategic move, ZimVie Inc. recognized globally for its leadership in the dental and spine markets, has finalized a definitive agreement to sell its spine business to H.I.G. Capital, a prominent global alternative investment firm. H.I.G. Capital, a global private equity firm, has a strong track record of successfully managing and growing businesses across various sectors. The $375 million investment underscores their confidence in the future potential and profitability of the spine industry.As the industry awaits the unfolding of this transformative transaction, speculation arises about the potential scenarios and hypotheses that might shape the future of ZimVie’s spine business under the new ownership.The primary objective behind ZimVie’s decision to sell its spine business is to leverage the after-tax proceeds for debt reduction, aligning with the company’s capital allocation priorities. ZimVie aims to position itself as a pure-play dental company in higher-growth end markets by streamlining operations and focusing on its core competency.

This strategic shift raises questions about the fate of its diverse spine portfolio.Given ZimVie’s extensive spine portfolio, including disc prostheses and tethering solutions, there is speculation about the potential for H.I.G. Capital to sell specific segments of the spine business individually. This approach could allow for a more targeted market strategy, capitalizing on the demand for specific spinal innovations. The diverse range of products in ZimVie’s spine division makes this hypothesis intriguing, and the market could witness a strategic sell-off to maximize value.The collaboration between H.I.G. Capital and ZimVie’s spine leadership team could lead to the foundation of a new standalone entity. This specialized medical device company might focus exclusively on spinal innovations, leveraging H.I.G. Capital’s expertise in the medical device space and ZimVie’s established capabilities. 

In conclusion, the strategic sale of ZimVie’s spine business to H.I.G. Capital introduces a myriad of possibilities for the future. Whether through business segmentation, the creation of a new entity, or a collaborative innovation engine, the industry awaits the unfolding narrative of ZimVie’s spine division. 

We would like to know what your opinion is on this topic! Comments are welcome!

Related Posts:

  • Why Investment Firms Are Eyeing Spinal Implant Companies?
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • H.I.G. Capital Acquires the Spine Business of ZimVie…

Filed Under: ARTICLES, NEWS Tagged With: 2024

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • PRODUCT LIBRARY
  • Who Is Really Winning the Mid-Tier Spine…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • What Is Medtronic’s PILAR™ Technique?
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Globus Medical Reports Fourth Quarter and Full Year…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Single-Use Spine Surgery Systems: The Future or…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • Expandable cages were adopted not because they fused…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • VB Spine Announces Successful First Clinical Cases…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • From Early Innovations to Modern Practice: Where Are…
  • VB Spine Announces VB Spine Solutions, a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Globus Medical Reports First Quarter 2026 Results
  • LAST 5 VIDEOS PUBLISHED

    1. REACH Medical: Expandable PLIF/TLIF Cage
    2. Expanding Innovations: X-PAC®TLIF 
    3. SI-BONE: iFuse INTRA Ti™ Implant System
    4. Globus Medical: IntraLIF™ Cannulated
    5. SI-BONE: iFuse TORQ TNT® Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup